VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Chief Scientific Officer | Nov 15, 2024 | Sale | $478.56 | 15 | 7,178 | 25,813 | Nov 19, 2024, 04:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Chief Scientific Officer | May 15, 2024 | Sale | $430.93 | 54 | 23,270 | 25,813 | May 17, 2024, 04:22 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 23, 2024 | Option Exercise | $431.79 | 3,970 | 1,714,206 | 30,052 | Feb 27, 2024, 04:24 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 26, 2024 | Sale | $425.70 | 4,239 | 1,804,542 | 25,813 | Feb 27, 2024, 04:24 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 21, 2024 | Sale | $421.77 | 3,002 | 1,266,154 | 34,022 | Feb 23, 2024, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 16, 2024 | Option Exercise | $424.01 | 3,750 | 1,590,038 | 43,838 | Feb 21, 2024, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 20, 2024 | Option Exercise | $420.58 | 2,812 | 1,182,671 | 41,026 | Feb 21, 2024, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 20, 2024 | Sale | $420.79 | 4,002 | 1,684,002 | 37,024 | Feb 21, 2024, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 09, 2024 | Option Exercise | $422.74 | 2,099 | 887,331 | 50,733 | Feb 13, 2024, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 12, 2024 | Sale | $420.24 | 3,145 | 1,321,655 | 47,588 | Feb 13, 2024, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2023 | Sale | $369.92 | 19 | 7,028 | 32,038 | Nov 17, 2023, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 09, 2023 | Sale | $345.51 | 63 | 21,767 | 32,038 | Aug 11, 2023, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 27, 2023 | Sale | $287.51 | 4,238 | 1,218,450 | 32,640 | Feb 28, 2023, 04:40 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 24, 2023 | Option Exercise | $289.12 | 3,970 | 1,147,806 | 36,276 | Feb 28, 2023, 04:40 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 17, 2023 | Option Exercise | $292.85 | 3,750 | 1,098,188 | 44,248 | Feb 22, 2023, 04:25 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 21, 2023 | Sale | $293.77 | 4,002 | 1,175,676 | 44,212 | Feb 22, 2023, 04:25 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 14, 2023 | Sale | $298.70 | 6,398 | 1,911,108 | 53,596 | Feb 16, 2023, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 13, 2023 | Sale | $298.90 | 4,798 | 1,434,126 | 58,949 | Feb 14, 2023, 04:49 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 10, 2023 | Option Exercise | $294.33 | 3,461 | 1,018,676 | 65,184 | Feb 14, 2023, 04:49 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 13, 2023 | Option Exercise | $298.26 | 5,990 | 1,786,577 | 59,194 | Feb 14, 2023, 04:49 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 06, 2023 | Option Exercise | $187.53 | 1,304 | 244,539 | 69,949 | Feb 08, 2023, 04:53 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 06, 2023 | Sale | $306.00 | 1,304 | 399,022 | 69,937 | Feb 08, 2023, 04:53 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2022 | Sale | $308.61 | 34 | 10,493 | 36,077 | Nov 17, 2022, 04:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 07, 2022 | Sale | $303.04 | 1,303 | 394,859 | 37,240 | Nov 09, 2022, 04:40 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 07, 2022 | Option Exercise | $187.53 | 1,303 | 244,352 | 37,380 | Nov 09, 2022, 04:40 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 08, 2022 | Option Exercise | $187.53 | 1,304 | 244,539 | 37,381 | Aug 10, 2022, 04:06 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 08, 2022 | Sale | $292.54 | 1,304 | 381,469 | 37,159 | Aug 10, 2022, 04:06 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jul 19, 2022 | Option Exercise | $174.33 | 17,765 | 3,096,948 | 53,942 | Jul 21, 2022, 04:48 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jul 19, 2022 | Sale | $288.65 | 17,865 | 5,156,730 | 52,979 | Jul 21, 2022, 04:48 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 24, 2022 | Option Exercise | $227.86 | 6,038 | 1,375,819 | 43,649 | Feb 28, 2022, 05:18 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 25, 2022 | Sale | $230.98 | 7,572 | 1,748,990 | 42,609 | Feb 28, 2022, 05:18 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 17, 2022 | Option Exercise | $232.51 | 3,439 | 799,602 | 53,999 | Feb 22, 2022, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 18, 2022 | Sale | $230.97 | 4,312 | 995,949 | 53,013 | Feb 22, 2022, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 14, 2022 | Sale | $232.02 | 2,444 | 567,057 | 57,438 | Feb 16, 2022, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 02, 2022 | Option Exercise | $86.52 | 4,660 | 403,183 | 70,357 | Feb 03, 2022, 04:06 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 02, 2022 | Sale | $251.47 | 4,660 | 1,171,842 | 69,857 | Feb 03, 2022, 04:06 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2021 | Sale | $187.22 | 34 | 6,365 | 33,609 | Nov 16, 2021, 04:04 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 17, 2021 | Sale | $216.36 | 79 | 17,093 | 33,660 | May 19, 2021, 04:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 24, 2021 | Option Exercise | $217.57 | 2,416 | 525,649 | 36,617 | Feb 26, 2021, 04:03 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 25, 2021 | Sale | $213.39 | 3,028 | 646,139 | 35,971 | Feb 26, 2021, 04:03 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 17, 2021 | Option Exercise | $211.75 | 6,240 | 1,321,320 | 46,858 | Feb 19, 2021, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 18, 2021 | Sale | $211.83 | 7,825 | 1,657,590 | 45,779 | Feb 19, 2021, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 11, 2021 | Sale | $210.54 | 5,283 | 1,112,274 | 53,598 | Feb 16, 2021, 04:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 10, 2021 | Option Exercise | $214.16 | 2,974 | 636,912 | 58,381 | Feb 12, 2021, 04:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 16, 2020 | Sale | $223.47 | 38 | 8,492 | 28,930 | Nov 18, 2020, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 06, 2020 | Option Exercise | $155.57 | 1,223 | 190,262 | 30,125 | Aug 10, 2020, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 06, 2020 | Sale | $271.19 | 1,223 | 331,663 | 29,635 | Aug 10, 2020, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 03, 2020 | Option Exercise | $86.52 | 2,330 | 201,592 | 31,232 | Aug 05, 2020, 04:14 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 03, 2020 | Sale | $278.24 | 2,330 | 648,290 | 30,774 | Aug 05, 2020, 04:14 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 15, 2020 | Sale | $284.37 | 82 | 23,318 | 28,982 | May 19, 2020, 04:21 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 12, 2020 | Option Exercise | $187.53 | 1,304 | 244,539 | 30,206 | May 14, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 12, 2020 | Sale | $287.33 | 1,304 | 374,678 | 28,902 | May 14, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 06, 2020 | Option Exercise | $155.57 | 1,222 | 190,107 | 30,124 | May 08, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 06, 2020 | Sale | $272.66 | 1,222 | 333,195 | 29,853 | May 08, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 04, 2020 | Sale | $260.86 | 2,330 | 607,803 | 30,532 | May 06, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 04, 2020 | Option Exercise | $86.52 | 2,330 | 201,592 | 31,232 | May 06, 2020, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 24, 2020 | Option Exercise | $239.23 | 2,416 | 577,980 | 31,930 | Feb 26, 2020, 04:29 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 25, 2020 | Sale | $233.41 | 3,028 | 706,776 | 31,196 | Feb 26, 2020, 04:29 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 17, 2020 | Option Exercise | $241.50 | 2,496 | 602,784 | 37,474 | Feb 19, 2020, 04:31 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 18, 2020 | Sale | $243.67 | 3,128 | 762,201 | 37,074 | Feb 19, 2020, 04:31 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 10, 2020 | Option Exercise | $240.95 | 13,308 | 3,206,563 | 57,002 | Feb 12, 2020, 05:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 11, 2020 | Sale | $246.11 | 17,032 | 4,191,771 | 56,002 | Feb 12, 2020, 05:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 06, 2020 | Option Exercise | $172.06 | 2,526 | 434,614 | 72,836 | Feb 07, 2020, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 06, 2020 | Sale | $239.42 | 2,526 | 604,775 | 71,374 | Feb 07, 2020, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 03, 2020 | Option Exercise | $88.49 | 4,126 | 365,117 | 35,679 | Feb 05, 2020, 04:50 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 03, 2020 | Sale | $231.18 | 4,126 | 953,861 | 34,930 | Feb 05, 2020, 04:50 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 25, 2019 | Option Exercise | $187.53 | 3,910 | 733,242 | 35,463 | Nov 26, 2019, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 25, 2019 | Sale | $219.37 | 3,910 | 857,737 | 31,553 | Nov 26, 2019, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2019 | Sale | $205.95 | 60 | 12,357 | 31,553 | Nov 19, 2019, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 06, 2019 | Option Exercise | $155.57 | 1,223 | 190,262 | 32,776 | Nov 07, 2019, 04:36 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 06, 2019 | Sale | $197.21 | 1,223 | 241,189 | 32,533 | Nov 07, 2019, 04:36 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 04, 2019 | Option Exercise | $88.49 | 4,126 | 365,117 | 35,679 | Nov 06, 2019, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 04, 2019 | Sale | $200.45 | 4,126 | 827,049 | 32,353 | Nov 06, 2019, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Oct 22, 2019 | Option Exercise | $155.57 | 3,669 | 570,786 | 35,222 | Oct 24, 2019, 07:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Oct 22, 2019 | Sale | $194.37 | 3,669 | 713,144 | 31,553 | Oct 24, 2019, 07:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 19, 2019 | Sale | $186.38 | 12,501 | 2,329,976 | 33,883 | Aug 20, 2019, 04:30 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 19, 2019 | Option Exercise | $103.25 | 12,501 | 1,290,681 | 36,212 | Aug 20, 2019, 04:30 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | May 15, 2019 | Sale | $165.41 | 91 | 15,052 | 31,553 | May 17, 2019, 04:16 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 19, 2019 | Sale | $187.00 | 5,624 | 1,051,716 | 32,604 | Feb 21, 2019, 04:21 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 11, 2019 | Sale | $180.22 | 32,956 | 5,939,188 | 60,050 | Feb 13, 2019, 04:36 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 04, 2019 | Option Exercise | $88.49 | 4,126 | 365,117 | 41,443 | Feb 06, 2019, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 04, 2019 | Sale | $189.19 | 4,126 | 780,598 | 39,113 | Feb 06, 2019, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jan 22, 2019 | Option Exercise | $131.89 | 2,125 | 280,266 | 41,238 | Jan 24, 2019, 04:45 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jan 22, 2019 | Sale | $193.48 | 2,125 | 411,145 | 39,113 | Jan 24, 2019, 04:45 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jan 18, 2019 | Option Exercise | $155.70 | 1,223 | 190,421 | 40,336 | Jan 22, 2019, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Jan 18, 2019 | Sale | $194.62 | 1,223 | 238,020 | 39,113 | Jan 22, 2019, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2018 | Sale | $163.75 | 100 | 16,375 | 39,113 | Nov 19, 2018, 05:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 07, 2018 | Option Exercise | $131.89 | 2,125 | 280,266 | 41,238 | Nov 08, 2018, 04:18 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 07, 2018 | Sale | $181.89 | 2,125 | 386,516 | 39,113 | Nov 08, 2018, 04:18 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 02, 2018 | Sale | $175.36 | 1,796 | 314,947 | 39,113 | Nov 06, 2018, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 05, 2018 | Option Exercise | $86.52 | 2,330 | 201,592 | 41,443 | Nov 06, 2018, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 05, 2018 | Sale | $172.08 | 2,330 | 400,946 | 39,113 | Nov 06, 2018, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 02, 2018 | Option Exercise | $91.05 | 1,796 | 163,526 | 40,909 | Nov 06, 2018, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Oct 01, 2018 | Option Exercise | $155.57 | 2,445 | 380,369 | 41,558 | Oct 02, 2018, 12:00 AM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Oct 01, 2018 | Sale | $194.62 | 2,445 | 475,846 | 39,113 | Oct 02, 2018, 12:00 AM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 28, 2018 | Option Exercise | $131.89 | 2,125 | 280,266 | 41,238 | Aug 30, 2018, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 28, 2018 | Sale | $181.89 | 2,125 | 386,516 | 39,113 | Aug 30, 2018, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 03, 2018 | Sale | $174.20 | 2,330 | 405,886 | 39,113 | Aug 06, 2018, 05:42 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 02, 2018 | Option Exercise | $91.05 | 1,796 | 163,526 | 40,909 | Aug 06, 2018, 05:42 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 02, 2018 | Sale | $174.59 | 1,796 | 313,564 | 39,113 | Aug 06, 2018, 05:42 PM |